For full functionality of this website it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser

Session Details

< Back to Agenda
The Sweden Ecosystem: A Route from Concept Creation to Product Delivery
Wednesday, September 4, 2024 08:00 AM - 09:00 AM  
F2
Concurrent Session
Chair
  • Johan Hyllner, PhD, AstraZeneca/Linköping University, Sweden
Speakers: 
  • Kristina Levan, PhD, Precision Medicine, Sweden - A Sustainable Ecosystem: The Key to successful implementation of ATMP in the healthcare 
  • Anna Falk, PhD, Lund University/CCRM Nordic, Sweden - An integrated and proactive ecosystem for sustainable ATMP development
  • Veronique Chotteau, PhD, KTH Royal Institute of Technology/AdBIOPRO, Sweden - Academia-industry collaboration as enabler to advance the technology to support commercial production of ATMP’s
This session will explore the integrated ecosystem in Sweden that facilitates the journey from concept creation to the commercial delivery of Advanced Therapy Medicinal Products (ATMPs). We will examine the pivotal roles played by academia, public and private funding, and industry collaborations in driving R&D. The session will also delve into the creation of a connected translational infrastructure, highlighting key initiatives such as AdBioPro, Lund GMP and CCRM Nordic, and their links to other efforts like NorthX and the Testa Centre. Finally, we will discuss the establishment of effective clinical delivery systems within Swedish hospital ATMP centers, ensuring a seamless transition from clinical trials to market success. Attendees will gain insights into the strategies and best practices that underpin successful ATMP commercialization.
 
Session Objectives 
  1. Understanding the Role of Academia and Industry Collaborations in R&D
  2. Exploring the Components of a Connected Translational Infrastructure
  3. Describing the Clinical Delivery System for ATMPs in Sweden
  4. Integrating R&D, Translational, and Clinical Delivery Phases
Johan Hyllner PhD
Executive Director
 AstraZeneca
 Chair
Veronique Chotteau PhD
Professor and Director of AdBIOPRO
 KTH
 Speakers
Anna Falk PhD
Professor
 Lund University
 Speakers
Kristina Levan MSc, PhD
Core team ATMP2030
 Sahlgrenska University Hospital
 Speakers
< Back to Agenda